Allergology
Allergology at Horev Medical: American Academy of Allergy guidelines recommend intranasal corticosteroids as first-line treatment for seasonal rhinitis in patients aged 12 and older.
Allergology at Horev Medical: American Academy of Allergy guidelines recommend intranasal corticosteroids as first-line treatment for seasonal rhinitis in patients aged 12 and older.
Allergic rhinitis
American Academy of Allergy, Asthma, and Immunology recommendations
- For initial treatment of seasonal allergic rhinitis in individuals aged ≥12 years,
monotherapy with intranasal corticosteroids is prescribed instead of a combination
of intranasal corticosteroids with an oral antihistamine. An oral antihistamine may be
added if there is no full response to intranasal corticosteroids.
- For initial treatment of seasonal allergic rhinitis in individuals aged ≥15 years,
intranasal corticosteroid therapy is recommended rather than leukotriene receptor
antagonists.
- For treatment of moderate to severe seasonal allergic rhinitis in individuals aged ≥12
years, a combination of intranasal corticosteroids and intranasal antihistamines
(azelastine) is recommended as primary therapy.
(Annals of Internal Medicine, December 12, 2017)
A large-scale pilot trial of the world's first vaccine offering partial protection from malaria for young children is launching in Malawi (Southern Africa), BBC reports. The vaccine activates the immune system so that the body itself attacks the malaria parasite. Earlier studies showed that nearly 40% of children aged 5-17 months were protected from malaria thanks to the vaccine.Book a visit — we will pick a convenient time.